3 Notable Runners: Corning Incorporated (GLW), CenturyLink, Inc. (CTL), Medtronic plc (MDT)

Corning Incorporated (GLW) managed to rebound with the stock climbing 1.53% or $0.37 to close the day at $24.56 on lower than average trading volume of 5.86M shares, compared to its three month average trading volume of 7.71M. The Corning New York 14831 based company has been outperforming the diversified electronics companies by 5.3588% for last three months and its recent gains have pushed the stock slightly up 1.19% YTD, versus the diversified electronics industry which is up 0.66% for the same period. The RSI of 52.87 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Corning Incorporated manufactures and sells specialty glasses, ceramics, and related materials worldwide. The company operates through five segments: Display Technologies, Optical Communications, Environmental Technologies, Specialty Materials, and Life Sciences. The Display Technologies segment manufactures glass substrates for liquid crystal displays (LCDs) used in LCD televisions, notebook computers, and flat panel desktop monitors. The Optical Communications segment manufactures optical fiber and cable; and hardware and equipment products comprising cable assemblies, fiber optic hardware and connectors, optical components and couplers, closures, network interface devices, and other accessories. This segment also offers subscriber demarcation, connection and protection devices, passive solutions, and outside plant enclosures; and coaxial RF interconnects for the cable television industry and microwave applications. The Environmental Technologies segment manufactures ceramic substrates and filter products for emissions control in mobile and stationary, and gasoline and diesel applications. The Specialty Materials segment manufactures products that provide approximately 150 material formulations for glass, glass ceramics, and fluoride crystals. The Life Sciences segment manufactures and supplies scientific laboratory products consisting of consumables, such as plastic vessels, specialty surfaces, and media, as well as general labware and equipment for cell culture research, bioprocessing, genomics, drug discovery, microbiology, and chemistry. It also engages in a pharmaceutical glass vessel and a tubing business; and precision materials’ non-LCD business, as well as precision laser cutting/shaping technologies, and flow reactors and adjacency businesses for glass. The company was formerly known as Corning Glass Works and changed its name to Corning Incorporated in April 1989. Corning Incorporated was founded in 1851 and is headquartered in Corning, New York.

CenturyLink, Inc. (CTL) had a active trading with around 5.84M shares changing hands compared to its three month average trading volume of 10.97M. The stock traded between $25.42 and $25.69 before closing at the price of $25.47 with 0% change on the day. The Monroe Louisiana 71203 based company is currently trading 25.54% above its 52 week low of $22.37 and -22.19% below its 52 week high of $33.45. Both the RSI indicator and target price of 64.26 and $28.08 respectively, lead us to believe that it should be put on hold over the coming weeks.

CenturyLink, Inc. provides various communications services to residential, business, wholesale, and governmental customers in the United States. It operates through two segments, Business and Consumer. The company offers high-speed Internet services, which allow customers to connect to the Internet through their existing telephone lines or fiber-optic cables; multi-protocol label switching, a data networking technology to support real-time voice and video; and private line services for the transmission of data between sites. It also provides Ethernet services, including point-to-point and multi-point equipment configurations that facilitate data transmissions across metropolitan areas and wide area networks (WAN); colocation services that enable its customers to install their own information technology (IT) equipment; and managed hosting services comprising cloud and traditional computing, application management, back-up, storage, and other services. In addition, the company offers video entertainment services and satellite digital television; Voice over Internet Protocol, a real-time, two-way voice communication service; and managed services that consist of network, hosting, cloud, and IT services. Further, it provides local calling, long-distance voice, integrated services digital network, WAN, and switched access services; and data integration, which includes the sale of telecommunications equipment and providing network management, installation, and maintenance of data equipment, and the building of proprietary fiber-optic broadband networks. Additionally, the company leases and subleases space in its office buildings, warehouses, and other properties. As of December 31, 2015, it served approximately 6 million high-speed Internet subscribers and 285 thousand television subscribers; and operated 59 data centers in North America, Europe, and Asia. CenturyLink, Inc. was founded in 1968 and is headquartered in Monroe, Louisiana.

Medtronic plc (MDT) traded within a range of $75.21 to $76.27 after opening the day at $76.27. The company has seen its stock increase in value by 6.23% so far this year. The stock was down close to -0.2% on light volume in last trading session and closed at $75.67 per share. After the recent fall, the stock is currently holding -14.73% below its 52 week high of $89.27 and 9.11% above its 12-month low of $69.35. The shares are down by over -7.81% in the last three months, and the RSI indicator value of 59.02 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Medtronic plc manufactures and sells device-based medical therapies worldwide. The company’s Cardiac and Vascular Group segment offers pacemakers, implantable cardioverter defibrillators and cardiac resynchronization therapy devices, AF products, diagnostics and monitoring devices, and remote monitoring and patient-centered software; and heart valves, percutaneous coronary intervention stent products, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular intervention products, and products to treat superficial and deep venous diseases. Its Minimally Invasive Therapies Group segment provides gastrointestinal diagnostics, ablation, and interventional lung solutions; stapling, vessel sealing, and other surgical instruments; sutures; electrosurgery products; hernia mechanical devices; mesh implants; products for patient monitoring and recovery; sensors; monitors; compression and dialysis, enteral feeding, and wound care products; and operating room supplies, electrodes, needles, syringes, and sharps disposals. The company’s Restorative Therapies Group segment offers products for various areas of the spine; bone graft substitutes; biologic products; trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis; products to treat conditions of the ear, nose, throat, and neurological disorders; systems that incorporate advanced energy surgical instruments; products for haemostatic sealing of soft tissue and bone; and image-guided surgery and intra-operative imaging systems. Its Diabetes Group segment provides insulin pumps and consumables; continuous glucose monitoring systems; and Web-based therapy management software solutions. It serves hospitals, physicians, clinicians, and patients. Medtronic plc was founded in 1949 and is headquartered in Dublin, Ireland.

 

Stocks Highlights: Medtronic plc (MDT), Transgenomic, Inc. (TBIO), MGM Resorts International (MGM)

Medtronic plc (MDT) had a active trading with around 7.08M shares changing hands compared to its three month average trading volume of 6.72M. The stock traded between $74.37 and $75.95 before closing at the price of $75.82 with 0.97% change on the day. The Dublin Dublin 2 based company is currently trading 9.33% above its 52 week low of $69.35 and -14.56% below its 52 week high of $89.27. Both the RSI indicator and target price of 61.13 and $84.55 respectively, lead us to believe that it should be put on hold over the coming weeks.

Medtronic plc manufactures and sells device-based medical therapies worldwide. The company’s Cardiac and Vascular Group segment offers pacemakers, implantable cardioverter defibrillators and cardiac resynchronization therapy devices, AF products, diagnostics and monitoring devices, and remote monitoring and patient-centered software; and heart valves, percutaneous coronary intervention stent products, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular intervention products, and products to treat superficial and deep venous diseases. Its Minimally Invasive Therapies Group segment provides gastrointestinal diagnostics, ablation, and interventional lung solutions; stapling, vessel sealing, and other surgical instruments; sutures; electrosurgery products; hernia mechanical devices; mesh implants; products for patient monitoring and recovery; sensors; monitors; compression and dialysis, enteral feeding, and wound care products; and operating room supplies, electrodes, needles, syringes, and sharps disposals. The company’s Restorative Therapies Group segment offers products for various areas of the spine; bone graft substitutes; biologic products; trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis; products to treat conditions of the ear, nose, throat, and neurological disorders; systems that incorporate advanced energy surgical instruments; products for haemostatic sealing of soft tissue and bone; and image-guided surgery and intra-operative imaging systems. Its Diabetes Group segment provides insulin pumps and consumables; continuous glucose monitoring systems; and Web-based therapy management software solutions. It serves hospitals, physicians, clinicians, and patients. Medtronic plc was founded in 1949 and is headquartered in Dublin, Ireland.

Transgenomic, Inc. (TBIO) continued its downward trend with the stock declining -12.24% or $-0.12 to close the day at $0.86 on active trading volume of 7.07M shares, compared to its three month average trading volume of 2.66M. The Omaha Nebraska 68164 based company has been outperforming the scientific & technical instruments group over the past 52 weeks, with the stock gaining 2.38%, compared to the industry which has advanced 40.15% over the same period. With RSI of 70.41, the stock should still continue to rise and get closer to its one year target estimate of $7, making it a hold for now.

Transgenomic, Inc., a biotechnology company, engages in advancing personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies, and clinical and research services primarily in the United States. The company provides genetic analytical laboratory services related to oncology and pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical and biotechnology companies. It employs various genomic testing service technologies, including ICE COLD-PCR, a proprietary platform technology that enables detection of multiple known and unknown mutations from virtually any sample type, including tissue biopsies, blood, urine, saliva, cell-free DNA, and circulating tumor cells. The company was founded in 1997 and is headquartered in Omaha, Nebraska.

MGM Resorts International (MGM) shares were up in last trading by 0.14% to $28.66. It experienced lighter than average volume on day. The stock decreased in value by almost -1.71% over the past week and fell -3.57% in the past month. It is currently trading 0.13% above its 50 day moving average and 14.26% above its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -6.4% decrease in value from its one year high of $30.62. The RSI indicator value of 46.57, lead us to believe that it is a hold for now.

MGM Resorts International, through its wholly owned subsidiaries, owns and/or operates casino resorts in the United States and China. The company operates through two segments, Wholly Owned Domestic Resorts and MGM China. Its casino resorts offer gaming, hotel, convention, dining, entertainment, retail, and other resort amenities. Its casino operations include various slots, table games, and race and sports book wagering. The company operates 12 wholly owned resorts in the United States; and MGM Macau resort and casino in China, as well as develops an integrated casino, hotel, and entertainment resort on the Cotai Strip, Macau. The company also owns and operates Shadow Creek golf course, Primm Valley Golf Club, and Fallen Oak golf course. The company serves premium gaming customers; leisure and wholesale travel customers; business travelers; and group customers, including conventions, trade associations, and small meetings. The company was formerly known as MGM MIRAGE and changed its name to MGM Resorts International in June 2010. MGM Resorts International was founded in 1986 and is based in Las Vegas, Nevada.

 

3 Stocks in Focus: Eli Lilly and Company (LLY), Lowe’s Companies, Inc. (LOW), Medtronic plc (MDT)

Eli Lilly and Company (LLY) climbed 0.32% during last trading as the stock added $0.25 to finish the day at $77.4 with about 5.6M shares changing hands, compared to its three month average trading volume of 6.12M. The $85.17B market cap company, which fluctuated between $76.38 and $78.12 during the day, currently situated 20.6% above its 52 week low of $64.18 and -6.43% away from its one year high of $84.8. The RSI of 65.35 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. It operates through two segments, Human Pharmaceutical Products and Animal Health Products. The company offers endocrinology products to treat diabetes; osteoporosis in postmenopausal women and men; human growth hormone deficiency and pediatric growth conditions; and testosterone deficiency. It also provides neuroscience products for the treatment of depressive disorders, diabetic peripheral neuropathic pain, anxiety disorders, fibromyalgia, and chronic musculoskeletal pain; schizophrenia; attention-deficit hyperactivity disorders; depressive, obsessive-compulsive, bulimia nervosa, and panic disorders; and positron emission tomography imaging of beta-amyloid neurotic plaques in adult brains. In addition, the company offers products for the treatment of non-small cell lung, colorectal, head and neck, pancreatic, metastatic breast, ovarian, bladder, and metastatic gastric cancers, as well as malignant pleural mesothelioma; and cardiovascular products. Further, it provides animal health products, such as cattle feed additives; protein supplements for cows; leanness and performance enhancers for swine and cattle; antibiotics to treat respiratory and other diseases in cattle, swine, and poultry; anticoccidial agents for poultry; and chewable tablets that kill fleas and prevent flea infestations, heartworm diseases, roundworm diseases, hookworm diseases, and whipworm diseases. Additionally, the company offers products to treat chronic manifestations of atopic dermatitis and congestive heart failure in dogs; and chronic allergic dermatitis and kidney diseases in cats. It has a clinical collaboration agreement with Athenex, Inc.; and a research agreement with AstraZeneca for the development of clinical candidate MEDI1814 as a disease-modifying treatment for Alzheimer’s disease. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Lowe’s Companies, Inc. (LOW) gained $0.57 to close the day at a new closing price of $72.15, a 0.8% increase in value from its previous closing price that moved the stock 16.71% above its 52 week low of $62.62. A total of 5.53M shares exchanged hands during the day compared with its three month average trading volume of 6.25M. The stock, which fluctuated between $71.39 and $72.61 during the day, currently situated -12.95% below its 52 week high. The stock is down by -3.35% in the past one month and up by 1.98% over the past three months. With a one year target estimate of $79.79 and RSI of 52.5, the stock still has upside potential, making it a hold for now.

Lowe’s Companies, Inc. operates as a home improvement retailer. It offers products for home maintenance, repair, remodeling, and decorating. The company provides home improvement products in various categories, such as lumber and building materials, tools and hardware, appliances, fashion fixtures, rough plumbing and electrical, lawn and garden, seasonal living, paint, flooring, millwork, kitchens, outdoor power equipment, and home fashions. It also offers installation services through independent contractors in various product categories; extended protection plans; and in-warranty and out-of-warranty repair services. The company sells its national brand-name merchandise and private branded products to homeowners, renters, and professional customers; and retail customers comprising individual homeowners and renters. As of January 29, 2016, it operated 1,857 home improvement and hardware stores in the United States, Canada, and Mexico. The company also sells its products through online sites comprising Lowes.com, Lowes.ca, and ATGstores.com, as well as through mobile applications. Lowe’s Companies, Inc. was founded in 1946 and is based in Mooresville, North Carolina.

Medtronic plc (MDT) had a light trading with around 5.46M shares changing hands compared to its three month average trading volume of 6.71M. The stock traded between $74.66 and $75.3 before closing at the price of $75.09 with -0.03% change on the day. The Dublin Dublin 2 based company is currently trading 8.28% above its 52 week low of $69.35 and -15.38% below its 52 week high of $89.27. Both the RSI indicator and target price of 59.3 and $84.55 respectively, lead us to believe that it should be put on hold over the coming weeks.

Medtronic plc manufactures and sells device-based medical therapies worldwide. The company’s Cardiac and Vascular Group segment offers pacemakers, implantable cardioverter defibrillators and cardiac resynchronization therapy devices, AF products, diagnostics and monitoring devices, and remote monitoring and patient-centered software; and heart valves, percutaneous coronary intervention stent products, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular intervention products, and products to treat superficial and deep venous diseases. Its Minimally Invasive Therapies Group segment provides gastrointestinal diagnostics, ablation, and interventional lung solutions; stapling, vessel sealing, and other surgical instruments; sutures; electrosurgery products; hernia mechanical devices; mesh implants; products for patient monitoring and recovery; sensors; monitors; compression and dialysis, enteral feeding, and wound care products; and operating room supplies, electrodes, needles, syringes, and sharps disposals. The company’s Restorative Therapies Group segment offers products for various areas of the spine; bone graft substitutes; biologic products; trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis; products to treat conditions of the ear, nose, throat, and neurological disorders; systems that incorporate advanced energy surgical instruments; products for haemostatic sealing of soft tissue and bone; and image-guided surgery and intra-operative imaging systems. Its Diabetes Group segment provides insulin pumps and consumables; continuous glucose monitoring systems; and Web-based therapy management software solutions. It serves hospitals, physicians, clinicians, and patients. Medtronic plc was founded in 1949 and is headquartered in Dublin, Ireland.

 

Stocks Highlights: Synchrony Financial (SYF), Applied Materials, Inc. (AMAT), Medtronic plc (MDT)

Synchrony Financial (SYF) had a light trading with around 6.48M shares changing hands compared to its three month average trading volume of 7M. The stock traded between $35.6 and $36.19 before closing at the price of $36.13 with -0.63% change on the day. The Stamford Connecticut 06902 based company is currently trading 56.84% above its 52 week low of $23.25 and -5.06% below its 52 week high of $38.06. Both the RSI indicator and target price of 49.85 and $39.74 respectively, lead us to believe that it should be put on hold over the coming weeks.

Synchrony Financial operates as a consumer financial services company in the United States. The company offers private label credit cards, dual cards, and small and medium-sized business credit products; and promotional financing for consumer purchases, such as private label credit cards and installment loans. It also provides promotional financing to consumers for elective healthcare procedures or services, such as dental, veterinary, cosmetic, vision, and audiology; debt cancellation products; and deposit products, including certificates of deposit, individual retirement, money market, and savings accounts, as well as accepts deposits through third-party securities brokerage firms. The company offers its credit products through programs established with a group of national and regional retailers, local merchants, manufacturers, buying groups, industry associations, and healthcare service providers; and deposit products through multiple channels, including online, print, and radio advertising. Synchrony Financial was incorporated in 2003 and is headquartered in Stamford, Connecticut. Synchrony Financial operates independently of GE Consumer Finance, Inc. as of November 17, 2015.

Applied Materials, Inc. (AMAT) failed to extend gains with the stock declining -0.48% or $-0.16 to close the day at $33.31 on active trading volume of 6.46M shares, compared to its three month average trading volume of 10.82M. The Santa Clara California 95054 based company has been outperforming the semiconductor equipment & materials group over the past 52 weeks, with the stock gaining 109.02%, compared to the industry which has advanced 47.54% over the same period. With RSI of 63.4, the stock should still continue to rise and get closer to its one year target estimate of $35.46, making it a hold for now.

Applied Materials, Inc. provides manufacturing equipment, services, and software to the semiconductor, display, and related industries worldwide. It operates through three segments: Semiconductor Systems, Applied Global Services, and Display and Adjacent Markets. The Semiconductor Systems segment develops, manufactures, and sells a range of manufacturing equipment used to fabricate semiconductor chips or integrated circuits. It offers products and technologies for transistor and interconnect fabrication, including epitaxy, ion implantation, oxidation and nitridation, rapid thermal processing, chemical vapor deposition, physical vapor deposition, chemical mechanical planarization, and electrochemical deposition; patterning, selective removal, and packaging products and systems that enable the transfer of patterns onto device structures; and metrology, inspection, and review systems for front- and back-end-of-line applications. The Applied Global Services segment provides integrated solutions to optimize equipment and fab performance and productivity, including spares, upgrades, services, remanufactured earlier generation equipment, and factory automation software for semiconductor, display, and other products. The Display and Adjacent Markets segment offers products for manufacturing liquid crystal displays, organic light-emitting diodes, and other display technologies for TVs, personal computers, tablets, smart phones, and other consumer-oriented devices, as well as equipment for flexible substrates. The company serves manufacturers of semiconductor wafers and chips, liquid crystal and other displays, and other electronic devices. Applied Materials, Inc. was founded in 1967 and is headquartered in Santa Clara, California.

Medtronic plc (MDT) shares were up in last trading by 0.9% to $75.11. It experienced lighter than average volume on day. The stock increased in value by almost 6.04% over the past week and grew 2.51% in the past month. It is currently trading -0.23% below its 50 day moving average and -7.52% below its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -15.36% decrease in value from its one year high of $89.27. The RSI indicator value of 57.27, lead us to believe that it is a hold for now.

Medtronic plc manufactures and sells device-based medical therapies worldwide. The company’s Cardiac and Vascular Group segment offers pacemakers, implantable cardioverter defibrillators and cardiac resynchronization therapy devices, AF products, diagnostics and monitoring devices, and remote monitoring and patient-centered software; and heart valves, percutaneous coronary intervention stent products, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular intervention products, and products to treat superficial and deep venous diseases. Its Minimally Invasive Therapies Group segment provides gastrointestinal diagnostics, ablation, and interventional lung solutions; stapling, vessel sealing, and other surgical instruments; sutures; electrosurgery products; hernia mechanical devices; mesh implants; products for patient monitoring and recovery; sensors; monitors; compression and dialysis, enteral feeding, and wound care products; and operating room supplies, electrodes, needles, syringes, and sharps disposals. The company’s Restorative Therapies Group segment offers products for various areas of the spine; bone graft substitutes; biologic products; trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis; products to treat conditions of the ear, nose, throat, and neurological disorders; systems that incorporate advanced energy surgical instruments; products for haemostatic sealing of soft tissue and bone; and image-guided surgery and intra-operative imaging systems. Its Diabetes Group segment provides insulin pumps and consumables; continuous glucose monitoring systems; and Web-based therapy management software solutions. It serves hospitals, physicians, clinicians, and patients. Medtronic plc was founded in 1949 and is headquartered in Dublin, Ireland.

 

Stocks Highlights: salesforce.com, inc. (CRM), Atwood Oceanics, Inc. (ATW), Medtronic plc (MDT)

salesforce.com, inc. (CRM) had a active trading with around 7.57M shares changing hands compared to its three month average trading volume of 6.74M. The stock traded between $74.06 and $76.08 before closing at the price of $75.77 with 2.42% change on the day. The San Francisco California 94105 based company is currently trading 44.05% above its 52 week low of $52.6 and -10.31% below its 52 week high of $84.48. Both the RSI indicator and target price of 68.79 and $94.87 respectively, lead us to believe that it should be put on hold over the coming weeks.

salesforce.com, inc. provides enterprise cloud computing solutions, with a focus on customer relationship management to various businesses and industries worldwide. It offers enterprise cloud computing applications and platform services, including Sales Cloud that enables companies to store data, monitor leads and progress, forecast opportunities, gain insights through relationship intelligence, and collaborate around sales on desktop and mobile devices. The company also provides Service Cloud that enables companies to deliver personalized customer service and support, as well as connects their service agents with customers on various devices; and Marketing Cloud, which enables companies to plan, personalize, and optimize customer interactions. In addition, it offers Community Cloud that enables companies to engage with groups of people by giving them access to information, applications, and experts; Analytics Cloud, an application, which enables companies to deploy sales, service, marketing, and custom analytics applications using various data source; Internet of Things Cloud that enables customers to process data, as well as build personalized actions and engage with customers in real time; and App Cloud, an application development platform for companies to deliver connected applications for various business needs. Further, the company provides professional services, including consulting, deployment, training, and design and integration services to facilitate the adoption of its cloud solutions, as well as offers various education service offerings ranging from introductory online courses to advanced architecture certifications. It sells and markets services primarily through its direct sales force, as well as through consulting firms, systems integrators, and regional partners. The company has a strategic alliance with Cisco to develop IoT and contact center platforms. salesforce.com, inc. was founded in 1999 and is headquartered in San Francisco, California.

Atwood Oceanics, Inc. (ATW) managed to rebound with the stock climbing 8.55% or $1.1 to close the day at $13.97 on active trading volume of 7.52M shares, compared to its three month average trading volume of 4.36M. The Houston Texas 77094 based company has been outperforming the oil & gas drilling & exploration group over the past 52 weeks, with the stock gaining 79.1%, compared to the industry which has advanced 108.3% over the same period. With RSI of 66.33, the stock should still continue to rise and get closer to its one year target estimate of $9.17, making it a hold for now.

Atwood Oceanics, Inc., an offshore drilling contractor, engages in the drilling and completion of exploratory and developmental oil and gas wells. As of November 11, 2016, it owned a fleet of 10 mobile offshore drilling units. The company operates its fleet in the United States, Gulf of Mexico, the Mediterranean Sea, offshore West Africa, offshore Southeast Asia, and offshore Australia. Atwood Oceanics, Inc. was founded in 1968 and is headquartered in Houston, Texas.

Medtronic plc (MDT) shares were down in last trading by -0.61% to $74.44. It experienced higher than average volume on day. The stock increased in value by almost 4.45% over the past week and grew 2.09% in the past month. It is currently trading -1.31% below its 50 day moving average and -8.34% below its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -16.11% decrease in value from its one year high of $89.27. The RSI indicator value of 54.3, lead us to believe that it is a hold for now.

Medtronic plc manufactures and sells device-based medical therapies worldwide. The company’s Cardiac and Vascular Group segment offers pacemakers, implantable cardioverter defibrillators and cardiac resynchronization therapy devices, AF products, diagnostics and monitoring devices, and remote monitoring and patient-centered software; and heart valves, percutaneous coronary intervention stent products, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular intervention products, and products to treat superficial and deep venous diseases. Its Minimally Invasive Therapies Group segment provides gastrointestinal diagnostics, ablation, and interventional lung solutions; stapling, vessel sealing, and other surgical instruments; sutures; electrosurgery products; hernia mechanical devices; mesh implants; products for patient monitoring and recovery; sensors; monitors; compression and dialysis, enteral feeding, and wound care products; and operating room supplies, electrodes, needles, syringes, and sharps disposals. The company’s Restorative Therapies Group segment offers products for various areas of the spine; bone graft substitutes; biologic products; trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis; products to treat conditions of the ear, nose, throat, and neurological disorders; systems that incorporate advanced energy surgical instruments; products for haemostatic sealing of soft tissue and bone; and image-guided surgery and intra-operative imaging systems. Its Diabetes Group segment provides insulin pumps and consumables; continuous glucose monitoring systems; and Web-based therapy management software solutions. It serves hospitals, physicians, clinicians, and patients. Medtronic plc was founded in 1949 and is headquartered in Dublin, Ireland.

 

Traders Recap: Novavax, Inc. (NVAX), Medtronic plc (MDT), Activision Blizzard, Inc. (ATVI)

Novavax, Inc. (NVAX) continued its upward trend with the stock climbing 0.7% or $0.01 to close the day at $1.43 on lower than average trading volume of 7.77M shares, compared to its three month average trading volume of 8.21M. The Gaithersburg Maryland 20878 based company has been outperforming the biotechnology companies by -23.9968% for last three months and its recent losses have trimmed gains to 13.49% YTD, versus the biotechnology industry which is up 3.62% for the same period. The RSI of 53.52 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Novavax, Inc., a clinical-stage vaccine company, focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. The company produces its vaccines using its proprietary recombinant nanoparticle vaccine technology. Its product pipeline includes respiratory syncytial virus (RSV) vaccine candidates for elderly and maternal immunization that are in Phase III clinical trials, as well as pediatric RSV candidate, which is in Phase I clinical trial; seasonal quadrivalent influenza and pandemic H7N9 vaccines, which are in Phase II clinical trials; vaccine candidate against Ebola Virus that is Phase I clinical trial, as well as combination respiratory vaccine candidate and seasonal influenza vaccine candidate that is in pre-clinical trial; and rabies G protein vaccine candidate, which is in Phase I/II clinical trial. The company also has pre-clinical stage programs for various infectious diseases, including the Middle East respiratory syndrome coronavirus; and develops technology for the production of immune stimulating saponin-based adjuvants. Novavax, Inc. was founded in 1987 and is headquartered in Gaithersburg, Maryland.

Medtronic plc (MDT) had a active trading with around 7.67M shares changing hands compared to its three month average trading volume of 6.62M. The stock traded between $74.12 and $75.27 before closing at the price of $74.9 with 1.46% change on the day. The Dublin Dublin 2 based company is currently trading 8% above its 52 week low of $69.35 and -16.1% below its 52 week high of $89.27. Both the RSI indicator and target price of 56.46 and $84.55 respectively, lead us to believe that it should be put on hold over the coming weeks.

Medtronic plc manufactures and sells device-based medical therapies worldwide. The company’s Cardiac and Vascular Group segment offers pacemakers, implantable cardioverter defibrillators and cardiac resynchronization therapy devices, AF products, diagnostics and monitoring devices, and remote monitoring and patient-centered software; and heart valves, percutaneous coronary intervention stent products, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular intervention products, and products to treat superficial and deep venous diseases. Its Minimally Invasive Therapies Group segment provides gastrointestinal diagnostics, ablation, and interventional lung solutions; stapling, vessel sealing, and other surgical instruments; sutures; electrosurgery products; hernia mechanical devices; mesh implants; products for patient monitoring and recovery; sensors; monitors; compression and dialysis, enteral feeding, and wound care products; and operating room supplies, electrodes, needles, syringes, and sharps disposals. The company’s Restorative Therapies Group segment offers products for various areas of the spine; bone graft substitutes; biologic products; trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis; products to treat conditions of the ear, nose, throat, and neurological disorders; systems that incorporate advanced energy surgical instruments; products for haemostatic sealing of soft tissue and bone; and image-guided surgery and intra-operative imaging systems. Its Diabetes Group segment provides insulin pumps and consumables; continuous glucose monitoring systems; and Web-based therapy management software solutions. It serves hospitals, physicians, clinicians, and patients. Medtronic plc was founded in 1949 and is headquartered in Dublin, Ireland.

Activision Blizzard, Inc. (ATVI) opening the day at $37.67. The company has seen its stock increase in value by 6.29% so far this year. The stock was up close to 1.8% on light volume in last trading session and closed at $38.38 per share. After the recent gain, the stock is currently holding -15.74% below its 52 week high of $45.55 and 46.06% above its 12-month low of $26.49. The shares are down by over -12.35% in the last three months, and the RSI indicator value of 58.8 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Activision Blizzard, Inc. develops and publishes online, personal computer (PC), video game console, handheld, mobile, and tablet games. The company operates through two segments, Activision Publishing, Inc. and Blizzard Entertainment, Inc. The company develops, publishes, and sells interactive software products and content through retail channels or digital downloads; and downloadable content to a range of gamers. It also publishes subscription-based massively multiplayer online role-playing games; and strategy and role-playing games. In addition, the company maintains a proprietary online gaming service, Battle.net that facilitates the creation of user generated content, digital distribution, and online social connectivity in its games. Further, it engages in creating original film and television content; and provides warehousing, logistical, and sales distribution services to third-party publishers of interactive entertainment software, as well as manufacturers of interactive entertainment hardware products. The company serves retailers and distributors, including mass-market retailers, consumer electronics stores, discount warehouses, game specialty stores, and consumers through third-party distribution, licensing arrangements, and direct digital purchases in the United States, Canada, Canada, the United Kingdom, France, Germany, Ireland, Italy, Sweden, Spain, the Netherlands, Australia, South Korea, China, and internationally. Activision Blizzard, Inc. is headquartered in Santa Monica, California.

 

Stocks on the Move: Merck & Co., Inc. (MRK), Medtronic plc (MDT), Regions Financial Corporation (RF)

Merck & Co., Inc. (MRK) continued its upward trend with the stock climbing 1.38% or $0.83 to close the day at $61.1 on active trading volume of 9.73M shares, compared to its three month average trading volume of 10.82M. The Kenilworth New Jersey 07033 based company has been outperforming the drug manufacturers – major group over the past 52 weeks, with the stock gaining 23.48%, compared to the industry which has advanced 8.16% over the same period. With RSI of 57.05, the stock should still continue to rise and get closer to its one year target estimate of $67.28, making it a hold for now.

Merck & Co., Inc. provides healthcare solutions worldwide. The company offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus, HIV-1 infection, fungal infections, intra-abdominal infections, hypertension, arthritis and pain, inflammatory, osteoporosis, male pattern hair loss, and fertility diseases. It also offers neuromuscular blocking agents; anti-bacterial products; cholesterol modifying medicines; non-sedating antihistamine; and vaginal contraceptive products. In addition, the company offers products to prevent chemotherapy-induced and post-operative nausea and vomiting; treat brain tumors; treat melanoma and metastatic non-small-cell lung cancer; prevent diseases caused by human papillomavirus; and vaccines for measles, mumps, rubella, varicella, chickenpox, shingles, rotavirus gastroenteritis, and pneumococcal diseases. Further, it offers antibiotic and anti-inflammatory drugs to treat infectious and respiratory diseases, fertility disorders, and pneumonia in cattle, horses, and swine; vaccines for poultry; parasiticide for sea lice in salmon; and antibiotics and vaccines for fishes. Additionally, the company offers companion animal products, such as ointments for otitis; diabetes mellitus treatment for dogs and cats; anthelmintic products; chewable tablets to treat fleas and ticks in dogs; and products for protection against bites from fleas, ticks, mosquitoes, and sandflies. It serves drug wholesalers and retailers, hospitals, government agencies and entities, physicians, physician distributors, veterinarians, distributors, animal producers, and managed health care providers. The company has collaboration agreements with Adaptimmune Therapeutics plc and Agenus; and a research agreement with Proteros Biostructures to develop molecule compounds for various cancer treatments. The company was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Medtronic plc (MDT) climbed 1.3% during last trading as the stock added $0.95 to finish the day at $73.82 with about 9.67M shares changing hands, compared to its three month average trading volume of 6.52M. The $101.87B market cap company, which fluctuated between $73.2 and $74.11 during the day, currently situated 6.45% above its 52 week low of $69.35 and -16.81% away from its one year high of $89.27. The RSI of 51.75 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Medtronic plc manufactures and sells device-based medical therapies worldwide. The company’s Cardiac and Vascular Group segment offers pacemakers, implantable cardioverter defibrillators and cardiac resynchronization therapy devices, AF products, diagnostics and monitoring devices, and remote monitoring and patient-centered software; and heart valves, percutaneous coronary intervention stent products, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular intervention products, and products to treat superficial and deep venous diseases. Its Minimally Invasive Therapies Group segment provides gastrointestinal diagnostics, ablation, and interventional lung solutions; stapling, vessel sealing, and other surgical instruments; sutures; electrosurgery products; hernia mechanical devices; mesh implants; products for patient monitoring and recovery; sensors; monitors; compression and dialysis, enteral feeding, and wound care products; and operating room supplies, electrodes, needles, syringes, and sharps disposals. The company’s Restorative Therapies Group segment offers products for various areas of the spine; bone graft substitutes; biologic products; trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis; products to treat conditions of the ear, nose, throat, and neurological disorders; systems that incorporate advanced energy surgical instruments; products for haemostatic sealing of soft tissue and bone; and image-guided surgery and intra-operative imaging systems. Its Diabetes Group segment provides insulin pumps and consumables; continuous glucose monitoring systems; and Web-based therapy management software solutions. It serves hospitals, physicians, clinicians, and patients. Medtronic plc was founded in 1949 and is headquartered in Dublin, Ireland.

Regions Financial Corporation (RF) saw its value decrease by -0.76% as the stock dropped $-0.11 to finish the day at a closing price of $14.37. The stock was lighter in trading and has fluctuated between $7-$14.73 per share for the past year. The shares, which traded within a range of $14.21 to $14.47 during the day, are up by 39.75% in the past three months and up by 69.56% over the past six months. It is currently trading -0.53% below its 20 day moving average and 8.91% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $14.48 a share over the next twelve months. The current relative strength index (RSI) reading is 59.82. The technical indicator lead us to believe there will be no major movement any time soon, hold.

Regions Financial Corporation, together with its subsidiaries, provides banking and bank-related services to individual and corporate customers in the United States. Its Corporate Bank segment offers commercial banking services, such as commercial and industrial, commercial real estate, and investor real estate lending, as well as equipment lease financing services. This segment serves corporate, middle market, small business, and commercial real estate developers and investors. The company’s Consumer Bank segment provides consumer banking products and services related to residential first mortgages, home equity lines and loans, small business loans, indirect loans, consumer credit cards, and other consumer loans, as well as the corresponding deposit relationships. Its Wealth Management segment offers wealth management products and services, including credit related products, trust and investment management, asset management, retirement and savings solutions, estate planning, and personal and commercial insurance products to individuals, businesses, governmental institutions, and non-profit entities. The company also provides insurance coverage for various lines of personal and commercial insurance, such as property, vehicle, casualty, life, health, and accident insurance, as well as commercial crop, life, and environmental insurance; and commercial equipment financing products, as well as offers securities, insurance, and advisory services through financial consultants. In addition, it offers securities brokerage, merger and acquisition advisory, trust, and other specialty financing services. As of December 31, 2015, the company operated 1,627 banking offices and 1,962 ATMs in Alabama, Arkansas, Florida, Georgia, Illinois, Indiana, Iowa, Kentucky, Louisiana, Mississippi, Missouri, North Carolina, South Carolina, Tennessee, Texas, and Virginia. Regions Financial Corporation was founded in 1971 and is headquartered in Birmingham, Alabama.

 

Stocks Alert: Morgan Stanley (MS), Gilead Sciences Inc. (GILD), Medtronic plc (MDT)

Morgan Stanley (MS) grew with the stock adding 1.46% or $0.63 to close at $43.85 on active trading volume of 9.14M compared its three months average trading volume of 12.05M. The New York New York 10036 based company operating under the Investment Brokerage – National industry has been trending up for the last 52 weeks, with the shares price now 55.02% up for the period and up by 3.79% so far this year. With price target of $42.02 and a 111.06% rebound from 52-week low, Morgan Stanley has plenty of upside potential, making it a hold with a view buy.

Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals worldwide. The company’s Institutional Securities segment offers capital raising and financial advisory services, including services related to the underwriting of debt, equity, and other securities, as well as advice on mergers and acquisitions, restructurings, real estate, and project finance. This segment also provides sales and trading services, such as sales, financing, and market-making services in equity securities and fixed income products, including foreign exchange and commodities, as well as prime brokerage services; and corporate lending services, credit products, and investments and research services. Its Wealth Management segment offers various financial services and solutions covering brokerage and investment advisory services, market-making services in fixed income securities, financial and wealth planning services, annuity and insurance products, credit and other lending products, and banking and retirement plan services to individual investors, small-to-medium sized businesses, and institutions. The company’s Investment Management segment provides various investment strategies and products comprising asset management, including equity, fixed income, liquidity, alternatives, and managed futures products. This segment is also involved in merchant banking and real estate investing businesses. Morgan Stanley was founded in 1924 and is headquartered in New York, New York.

Gilead Sciences Inc. (GILD) dropped $-0.52 to close the day at a new closing price of $75.49, a -0.68% decrease in value from its previous closing price that moved the stock 7.27% above its 52 week low of $70.83. A total of 8.97M shares exchanged hands during the day compared with its three month average trading volume of 9.61M. The stock, which fluctuated between $75.41 and $76.5 during the day, currently situated -25.44% below its 52 week high. The stock is up by 4.84% in the past one month and down by -0.31% over the past three months. With a one year target estimate of $95.19 and RSI of 57.61, the stock still has upside potential, making it a hold for now.

Gilead Sciences Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical needs in North America, South America, Europe, and the Asia-Pacific. The company’s products include Genvoya, Stribild, Complera/Eviplera, Atripla, Truvada, Viread, Emtriva, Tybost, and Vitekta for the treatment of human immunodeficiency virus (HIV) infection in adults; and Harvoni, Sovaldi, Viread, and Hepsera products for the treatment of liver diseases. It also offers Zydelig, a PI3K delta inhibitor, in combination with rituximab, for the treatment of certain blood cancers; Letairis, an endothelin receptor antagonist for the treatment of pulmonary arterial hypertension; Ranexa, a tablet used for the treatment of chronic angina; Lexiscan/Rapiscan injection for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging; Cayston, an inhaled antibiotic for the treatment of respiratory systems in cystic fibrosis patients; and Tamiflu, an oral antiviral capsule for the treatment and prevention of influenza A and B. In addition, the company provides other products, such as AmBisome, an antifungal agent to treat serious invasive fungal infections; and Macugen, an anti-angiogenic oligonucleotide to treat neovascular age-related macular degeneration. Further, it has product candidates in various stages of development for the treatment of HIV/AIDS and liver diseases, such as hepatitis B virus and hepatitis C virus; inflammation/oncology; serious cardiovascular; and respiratory conditions, as well as diabetic nephropathy and ebola. The company markets its products through its commercial teams and/or in conjunction with third-party distributors and corporate partners. Gilead Sciences Inc. has collaboration agreements with Bristol-Myers Squibb Company, Janssen R&D Ireland, Japan Tobacco Inc., and Galapagos NV. The company was founded in 1987 and is headquartered in Foster City, California.

Medtronic plc (MDT) shares were up in last trading by 2.88% to $72.87. It experienced higher than average volume on day. The stock increased in value by almost 1.86% over the past week and grew 1.66% in the past month. It is currently trading -3.94% below its 50 day moving average and -10.27% below its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -17.88% decrease in value from its one year high of $89.27. The RSI indicator value of 47.16, lead us to believe that it is a hold for now.

Medtronic plc manufactures and sells device-based medical therapies worldwide. The company’s Cardiac and Vascular Group segment offers pacemakers, implantable cardioverter defibrillators and cardiac resynchronization therapy devices, AF products, diagnostics and monitoring devices, and remote monitoring and patient-centered software; and heart valves, percutaneous coronary intervention stent products, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular intervention products, and products to treat superficial and deep venous diseases. Its Minimally Invasive Therapies Group segment provides gastrointestinal diagnostics, ablation, and interventional lung solutions; stapling, vessel sealing, and other surgical instruments; sutures; electrosurgery products; hernia mechanical devices; mesh implants; products for patient monitoring and recovery; sensors; monitors; compression and dialysis, enteral feeding, and wound care products; and operating room supplies, electrodes, needles, syringes, and sharps disposals. The company’s Restorative Therapies Group segment offers products for various areas of the spine; bone graft substitutes; biologic products; trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis; products to treat conditions of the ear, nose, throat, and neurological disorders; systems that incorporate advanced energy surgical instruments; products for haemostatic sealing of soft tissue and bone; and image-guided surgery and intra-operative imaging systems. Its Diabetes Group segment provides insulin pumps and consumables; continuous glucose monitoring systems; and Web-based therapy management software solutions. It serves hospitals, physicians, clinicians, and patients. Medtronic plc was founded in 1949 and is headquartered in Dublin, Ireland.

 

Momentum Stocks: Office Depot, Inc. (ODP), Medtronic plc (MDT), Boston Scientific Corporation (BSX)

Office Depot, Inc. (ODP) retreated with the stock falling -0.86% or $-0.04 to close at $4.61 on light trading volume of 6.23M compared its three months average trading volume of 8.48M. The Boca Raton Florida 33496 based company operating under the Specialty Retail, Other industry has been trending down for the last 52 weeks, with the shares price now -18.25% down for the period and up by 1.99% so far this year. With price target of $4.99 and a 53.99% rebound from 52-week low, Office Depot, Inc. has plenty of upside potential, making it a hold with a view buy.

Office Depot, Inc., together with its subsidiaries, supplies office products and services. It operates in three segments: North American Retail, North American Business Solutions, and International. The company sells office supplies, technology products and solutions, business machines and related supplies, facilities products, and office furniture. It also offers copy and print services. The company sells its products and services to consumers and businesses through office supply stores, a contract sales force, Internet sites, an outbound telephone account management sales force, direct marketing catalogs, and call centers, as well as participates under licensing and merchandise arrangements in Latin America, Europe, Israel, and Japan. As of December 26, 2015, it operated 1,564 stores in the United States, including Puerto Rico and the U.S. Virgin Islands; and 147 stores in France, South Korea, Sweden, New Zealand, and Australia. The company offers its products under various labels, including Office Depot, OfficeMax, Foray, Ativa, TUL, Realspace, WorkPro, Brenton Studio, Highmark, Grand & Toy, and Viking Office Products. Office Depot, Inc. was founded in 1986 and is headquartered in Boca Raton, Florida.

Medtronic plc (MDT) had a light trading with around 6.22M shares changing hands compared to its three month average trading volume of 6.38M. The stock traded between $70.59 and $71.51 before closing at the price of $70.83 with -0.62% change on the day. The Dublin Dublin 2 based company is currently trading 2.13% above its 52 week low of $69.35 and -20.18% below its 52 week high of $89.27. Both the RSI indicator and target price of  and $85.5 respectively, lead us to believe that it could rise over the coming weeks.

Medtronic plc manufactures and sells device-based medical therapies worldwide. The company’s Cardiac and Vascular Group segment offers pacemakers, implantable cardioverter defibrillators and cardiac resynchronization therapy devices, AF products, diagnostics and monitoring devices, and remote monitoring and patient-centered software; and heart valves, percutaneous coronary intervention stent products, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular intervention products, and products to treat superficial and deep venous diseases. Its Minimally Invasive Therapies Group segment provides gastrointestinal diagnostics, ablation, and interventional lung solutions; stapling, vessel sealing, and other surgical instruments; sutures; electrosurgery products; hernia mechanical devices; mesh implants; products for patient monitoring and recovery; sensors; monitors; compression and dialysis, enteral feeding, and wound care products; and operating room supplies, electrodes, needles, syringes, and sharps disposals. The company’s Restorative Therapies Group segment offers products for various areas of the spine; bone graft substitutes; biologic products; trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis; products to treat conditions of the ear, nose, throat, and neurological disorders; systems that incorporate advanced energy surgical instruments; products for haemostatic sealing of soft tissue and bone; and image-guided surgery and intra-operative imaging systems. Its Diabetes Group segment provides insulin pumps and consumables; continuous glucose monitoring systems; and Web-based therapy management software solutions. It serves hospitals, physicians, clinicians, and patients. Medtronic plc was founded in 1949 and is headquartered in Dublin, Ireland.

Boston Scientific Corporation (BSX) saw its value decrease by -0.14% as the stock dropped $-0.03 to finish the day at a closing price of $22.05. The stock was lighter in trading and has fluctuated between $15.67-$24.79 per share for the past year. The shares, which traded within a range of $22.01 to $22.22 during the day, are down by -5.89% in the past three months and down by -6.8% over the past six months. It is currently trading 3.1% above its 20 day moving average and 2.98% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $27.66 a share over the next twelve months. The current relative strength index (RSI) reading is 63.11.The technical indicator lead us to believe there will be no major movement any time soon, hold.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: Cardiovascular, Rhythm Management, and MedSurg. The company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; coronary technology products to treat atherosclerosis; intraluminal catheter-directed ultrasound imaging catheters and systems for use in coronary arteries and heart chambers, as well as peripheral vessels; and structural heart therapy systems. It also provides stents, balloon catheters, wires, peripheral embolization devices, and vena cava filters used to treat peripheral disease; and biliary stents, drainage catheters, and micro-puncture sets to treat, diagnose, and ease benign and malignant tumors. In addition, the company offers cardiac rhythm management devices, such as implantable cardioverter defibrillator systems to detect and treat abnormally fast heart rhythms; implantable cardiac resynchronization therapy pacemaker systems used to treat heart failure; and medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising steerable radio frequency ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories. Further, it provides products to diagnose and treat diseases of the pulmonary and gastrointestinal conditions; devices to diagnose, treat, and ease pulmonary disease systems within the airway and lungs; products to treat urinary stone disease and benign prostatic hyperplasia; mid-urethral sling products, sling and graft materials, pelvic floor reconstruction kits, and suturing devices; and spinal cord stimulator systems. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.

 

Trader’s Round Up: Delta Air Lines, Inc. (DAL), Netflix, Inc. (NFLX), Medtronic plc (MDT)

Delta Air Lines, Inc. (DAL) grew with the stock adding 2.47% or $1.22 to close at $50.7 on light trading volume of 7.9M compared its three months average trading volume of 9.36M. The Atlanta Georgia 30354 based company operating under the Major Airlines industry has been trending up for the last 52 weeks, with the shares price now 6.12% up for the period and up by 3.07% so far this year. With price target of $58.33 and a 57.1% rebound from 52-week low, Delta Air Lines, Inc. has plenty of upside potential, making it a hold with a view buy.

Delta Air Lines, Inc. provides scheduled air transportation for passengers and cargo in the United States and internationally. The company operates through two segments, Airline and Refinery. Its route network is centered around a system of hubs, international gateways, and airports in Amsterdam, Atlanta, Boston, Detroit, London-Heathrow, Los Angeles, Minneapolis-St. Paul, New York-LaGuardia, New York-JFK, Paris-Charles de Gaulle, Salt Lake City, Seattle, and Tokyo-Narita. The company sells its tickets through various distribution channels, including delta.com and mobile, telephone reservations, traditional brick and mortar, and online travel agencies. It also provides aircraft maintenance, repair, and overhaul services; staffing, and professional security and training services, as well as aviation solutions to third parties; vacation packages to third-party consumers; and aircraft charters, and aircraft management and programs. As of February 3, 2016, the company operated a fleet of approximately 800 aircrafts. Delta Air Lines, Inc. was founded in 1924 and is headquartered in Atlanta, Georgia.

Netflix, Inc. (NFLX) gained $1.92 to close the day at a new closing price of $129.41, a 1.51% increase in value from its previous closing price that moved the stock 61.86% above its 52 week low of $79.95. A total of 7.83M shares exchanged hands during the day compared with its three month average trading volume of 8.63M. The stock, which fluctuated between $126.55 and $130.17 during the day, currently situated 0.09% above its 52 week high. The stock is up by 7.12% in the past one month and up by 26.45% over the past three months. With a one year target estimate of $124.35 and RSI of 62.82, the stock still has upside potential, making it a hold for now.

Netflix, Inc., an Internet television network, engages in the Internet delivery of television (TV) shows and movies on various Internet-connected screens. The company operates in three segments: Domestic streaming, International streaming and Domestic DVD. It offer members with the ability to receive TV shows and movies streaming content, including original series, documentaries, and feature films through a host of Internet-connected screens, such as TVs, digital video players, TV set-top boxes, and mobile devices. The company also provides DVDs-by-mail membership services. As of October 17, 2016, it served approximately 86 million streaming members in 190 countries. Netflix, Inc. was founded in 1997 and is headquartered in Los Gatos, California.

Medtronic plc (MDT) shares were up in last trading by 0.93% to $71.27. It experienced higher than average volume on day. The stock decreased in value by almost -0.7% over the past week and fell -0.44% in the past month. It is currently trading -6.64% below its 50 day moving average and -12.27% below its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -19.69% decrease in value from its one year high of $89.27. The RSI indicator value of 36.65, lead us to believe that it is a hold for now.

Medtronic plc manufactures and sells device-based medical therapies worldwide. The company’s Cardiac and Vascular Group segment offers pacemakers, implantable cardioverter defibrillators and cardiac resynchronization therapy devices, AF products, diagnostics and monitoring devices, and remote monitoring and patient-centered software; and heart valves, percutaneous coronary intervention stent products, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular intervention products, and products to treat superficial and deep venous diseases. Its Minimally Invasive Therapies Group segment provides gastrointestinal diagnostics, ablation, and interventional lung solutions; stapling, vessel sealing, and other surgical instruments; sutures; electrosurgery products; hernia mechanical devices; mesh implants; products for patient monitoring and recovery; sensors; monitors; compression and dialysis, enteral feeding, and wound care products; and operating room supplies, electrodes, needles, syringes, and sharps disposals. The company’s Restorative Therapies Group segment offers products for various areas of the spine; bone graft substitutes; biologic products; trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis; products to treat conditions of the ear, nose, throat, and neurological disorders; systems that incorporate advanced energy surgical instruments; products for haemostatic sealing of soft tissue and bone; and image-guided surgery and intra-operative imaging systems. Its Diabetes Group segment provides insulin pumps and consumables; continuous glucose monitoring systems; and Web-based therapy management software solutions. It serves hospitals, physicians, clinicians, and patients. Medtronic plc was founded in 1949 and is headquartered in Dublin, Ireland.